Agenus | AGEN - Pre Tax Profit


Agenus reported $39.21M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
AbbVie USD 7.61B 2.04B Jun/2026
Agenus USD 39.21M 49.82M Mar/2026
Amgen USD 2.08B 570M Mar/2026
AstraZeneca USD 4.81B 894M Jun/2026
Bristol-Myers Squibb USD 4.99B 1.75B Jun/2026
Celldex Therapeutics USD -78.68M 2.63M Mar/2026
CSL USD 2.61B 1.21B Dec/2025
Eli Lilly USD 8.85B 583.8M Mar/2026
Gilead Sciences USD -7.53B 10.11B Jun/2026
GlaxoSmithKline GBP 2.68B 532M Jun/2026
Glaxosmithkline GBP 2.14B 312M Mar/2026
Incyte USD 751.51M 407.91M Jun/2026
Intrexon USD -60.48M 27.09M Jun/2024
J&J USD 7.67B 988M Sep/2026
Jiangsu Hengrui CNY 2.4B 161.31M Jun/2026
Karyopharm Therapeutics USD -22.39M 17.51M Mar/2026
MacroGenics USD -36.77M 21.84M Mar/2026
Merck EUR 869M 468M Mar/2026
Merck USD -3.53B 6.95B Mar/2026
Novartis USD 4.27B 430M Jun/2026
Novavax USD 17.9M 220.94M Dec/2025
Pfizer USD -653M 5.84B Jun/2026
Regeneron Pharmaceuticals USD 1.53B 696.6M Jun/2026
Rigel Pharmaceuticals USD -1.03M 7.22M Jun/2024
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
Veracyte USD 26.52M 3.45M Jun/2026